Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
ATN International
ATNI
$365M
| $3.41M | ﹤0.01% |
149,721
+36,658
| +32% | +$679K |
|
4377
Gaotu Techedu
GOTU
$405M
| $3.41M | ﹤0.01% |
1,469,385
-499,913
| -25% | -$1.35M |
|
4378
Orthofix Medical
OFIX
$492M
| $3.41M | ﹤0.01% |
224,643
+52,238
| +30% | +$797K |
|
4379
-1x Short VIX Futures ETF
SVIX
$159M
| $3.4M | ﹤0.01% |
140,512
+32,897
| +31% | +$675K |
|
4380
Aldeyra Therapeutics
ALDX
$97.1M
| $3.4M | ﹤0.01% |
657,032
-426,287
| -39% | -$2.19M |
|
|
BFK
4381
DELISTED
BlackRock Municipal Income Trust
BFK
| $3.4M | ﹤0.01% |
339,289
+3,153
| +0.9% | +$31.5K |
|
4382
Matrix Service
MTRX
$312M
| $3.4M | ﹤0.01% |
290,322
-1,530
| -0.5% | -$19.2K |
|
4383
American Battery Technology Co
ABAT
$280M
| $3.39M | ﹤0.01% |
1,015,801
+814,251
| +404% | +$3.81M |
|
4384
Global Industrial
GIC
$1.38B
| $3.39M | ﹤0.01% |
115,910
-8,401
| -7% | -$256K |
|
4385
BlueLinx
BXC
$430M
| $3.39M | ﹤0.01% |
55,130
-7,935
| -13% | -$512K |
|
4386
Village Farms International
VFF
$240M
| $3.37M | ﹤0.01% |
922,464
-641
| -0.1% | -$2.23K |
|
4387
Invesco S&P SmallCap Health Care ETF
PSCH
$162M
| $3.37M | ﹤0.01% |
76,416
+23,147
| +43% | +$1.01M |
|
4388
SELLAS Life Sciences
SLS
$1.99B
| $3.36M | ﹤0.01% |
890,929
-163,862
| -16% | -$318K |
|
4389
JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF
BBCB
$45.5M
| $3.35M | ﹤0.01% |
73,064
+13,141
| +22% | +$606K |
|
|
ONTF
4390
DELISTED
ON24
ONTF
| $3.34M | ﹤0.01% |
419,851
+50,482
| +14% | +$286K |
|
4391
Lineage Cell Therapeutics
LCTX
$264M
| $3.34M | ﹤0.01% |
1,998,663
+992,212
| +99% | +$1.72M |
|
4392
Home Bancorp
HBCP
$558M
| $3.34M | ﹤0.01% |
57,701
+11,769
| +26% | +$655K |
|
4393
Digimarc Corp
DMRC
$143M
| $3.33M | ﹤0.01% |
507,460
+76,095
| +18% | +$645K |
|
|
UPB
4394
Upstream Bio Inc
UPB
$349M
| $3.31M | ﹤0.01% |
122,068
+34,533
| +39% | +$860K |
|
4395
First Trust Active Global Quality Income ETF
AGQI
$54.7M
| $3.31M | ﹤0.01% |
200,858
-2,078
| -1% | -$33.7K |
|
4396
First Mid Bancshares
FMBH
$1.4B
| $3.29M | ﹤0.01% |
84,477
+35,901
| +74% | +$1.37M |
|
|
BCYC
4397
Bicycle Therapeutics
BCYC
$269M
| $3.29M | ﹤0.01% |
465,222
-357,483
| -43% | -$2.64M |
|
4398
Clean Energy Fuels
CLNE
$416M
| $3.29M | ﹤0.01% |
1,568,054
-823,054
| -34% | -$2.01M |
|
|
MCI
4399
Barings Corporate Investors
MCI
$345M
| $3.29M | ﹤0.01% |
181,313
-3,624
| -2% | -$73.7K |
|
|
HEQ
4400
John Hancock Hedged Equity & Income Fund
HEQ
$137M
| $3.29M | ﹤0.01% |
305,817
-122,647
| -29% | -$1.32M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.